
Sign up to save your podcasts
Or


For decades, regular mammograms to detect breast cancer have been recommended for women ages 50-75. In 2024, the age range dropped to include women 40-49 as well. But what do we really know about mammography as a tool to save lives? Are all scans created equal? What is the risk/benefit analysis to upping the number of screenings a woman is recommended to receive in her lifetime? In today's episode: a deep dive into the evidence around mammography, and a look at the new guidelines—including the controversy around them.
Guest:Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control whose work focuses on developing cancer screening strategies and ensuring their effectiveness. He is a Bloomberg Distinguished Professor and faculty at the Johns Hopkins Bloomberg School of Public Health in epidemiology with a joint appointment in oncology at Johns Hopkins Medicine. He was the former Chief Medical Officer of the American Cancer Society.
Host:Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health.
Show links and related content:Final Recommendation Statement: Breast Cancer Screening—U.S. Preventive Services Task Force
The Rise of Colorectal Cancer Among Younger People—Public Health On Call (June 2024)
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:@PublicHealthPod on X
@JohnsHopkinsSPH on Instagram
@JohnsHopkinsSPH on Facebook
@PublicHealthOnCall on YouTube
Here's our RSS feed
By The Johns Hopkins Bloomberg School of Public Health4.6
618618 ratings
For decades, regular mammograms to detect breast cancer have been recommended for women ages 50-75. In 2024, the age range dropped to include women 40-49 as well. But what do we really know about mammography as a tool to save lives? Are all scans created equal? What is the risk/benefit analysis to upping the number of screenings a woman is recommended to receive in her lifetime? In today's episode: a deep dive into the evidence around mammography, and a look at the new guidelines—including the controversy around them.
Guest:Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control whose work focuses on developing cancer screening strategies and ensuring their effectiveness. He is a Bloomberg Distinguished Professor and faculty at the Johns Hopkins Bloomberg School of Public Health in epidemiology with a joint appointment in oncology at Johns Hopkins Medicine. He was the former Chief Medical Officer of the American Cancer Society.
Host:Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health.
Show links and related content:Final Recommendation Statement: Breast Cancer Screening—U.S. Preventive Services Task Force
The Rise of Colorectal Cancer Among Younger People—Public Health On Call (June 2024)
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:@PublicHealthPod on X
@JohnsHopkinsSPH on Instagram
@JohnsHopkinsSPH on Facebook
@PublicHealthOnCall on YouTube
Here's our RSS feed

43,647 Listeners

40 Listeners

5 Listeners

26 Listeners

5 Listeners

259 Listeners

56,739 Listeners

493 Listeners

9 Listeners

45 Listeners

92 Listeners

16,356 Listeners

16 Listeners

4,782 Listeners

2 Listeners

4,482 Listeners

389 Listeners

6,561 Listeners

25 Listeners

6,425 Listeners

232 Listeners

67 Listeners

167 Listeners

110 Listeners